Storage and handling
IMPORTANT: Stored between 40° to 78° F (4°-26°C). Protect from freezing.
IMPORTANT: Stored between 40° to 78° F (4°-26°C). Protect from freezing.
INDICATIONS:
VITAL E–A+D3 is a clear, sterile, non-aqueous solution of vitamins A, Vitamin D and Vitamin E. The product is intended as a supplemental source of vitamin A, vitamin D and vitamin E for cattle, sheep, and swine.
Natural Vitamin A (carotenoids) and tocopherols can be destroyed in feedstuffs through processing, ensiling, and storage. Due to those losses reduced intakes of fat-soluble vitamins can in animals maintained in continual confinement compared top animals allowed to graze lush pasture. Intramuscular or subcutaneous injections offer an efficient and rapid method to increase vitamin A, vitamin D, and vitamin E status of the animals.
Vitamin A activity is provided as retinyl palmitate, the biological storage form of vitamin A and vitamin E activity is provided as d-alpha-tocopherol, the natural and biologically active form of vitamin E.
ADMINISTRATION AND DOSAGE:
Intramuscular or Subcutaneous Adminstration Only, may be repeated. If dose is greater than 5 mL, equally divide dose and inject at two different sites.
SUGGESTED DOSAGE:
CATTLE (Dairy and Beef)
Cows and Heifers 8-10 mL
Calves
At Birth 4-6 mL
At Weaning 4-6 mL
Yearlings 5-6 mL
SHEEP
Ewes 4-5 mL
Lambs
At Birth: .5-1 mL
At Weaning 2-3 mL
SWINE
Sows and Gilts
2 wks pre-partum 4-6 mL
2 wks pre-breeding 4-6 mL
Pigs
At births .25-.50 mL
Weaning: 1-2 mL
CAUTION: Anaphylactoid or allergic reactions, which may result in deaths, abortion, and/or premature births, may occur in individual animals as well as entire herds. Should such reactions or hypersensitivity occur, treat immediately with injection of epinephrine and/or antihistamines.
Do Not Exceed Recommended Dosage.
IMPORTANT: Stored between 40° to 78° F (4°-26°C). Protect from freezing.
®VITAL-E is a registered trademark of
STUARTPRODUCTS, INC.
STUART PRODUCTS INC
VITAL E® - A+D3
Vitamin A, D and E Injection
NOT FOR HUMAN USE
KEEP OUT OF REACH OF CHILDREN
Each ml contains: 100,000 I.U. Vitamin A, 10,000 I.U. Vitamin D and 300 I.U. vitamin E (as d-alpha-tocopherol) compounded with 18% ethyl alcohol and 1% benzyl alcohol (preservative) in an emulsifiable base.
NET CONTENTS: 250 mL
Manufactured in Mexico for
STUART PRODUCTS, INC.
112 Bedford Road
Bedford, Texas 76022
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1716012 | alpha tocopherol 300 UNT/ML / cholecalciferol 10,000 UNT/ML / vitamin A 100,000 UNT/ML Injectable Solution | PSN | 1 |
| 1716031 | Vital E- A + D3 300 UNT/ML / 10,000 UNT/ML / 100,000 UNT/ML Injectable Solution | PSN | 1 |
| 1716031 | alpha tocopherol 300 UNT/ML / cholecalciferol 10000 UNT/ML / vitamin A 100000 UNT/ML Injectable Solution [Vital E- A + D3] | SBD | 1 |
| 1716012 | alpha tocopherol 300 UNT/ML / cholecalciferol 10000 UNT/ML / vitamin A 100000 UNT/ML Injectable Solution | SCD | 1 |
| 1716031 | Vital E- A + D3 (cholecalciferol 10000 UNT/ML / vitamin A 100000 UNT/ML / vitamin E 300 UNT/ML) Injectable Solution | SY | 1 |
| 1716031 | Vital E- A + D3 (vitamin A 100000 UNT/ML / vitamin D3 10000 UNT/ML / vitamin E 300 UNT/ML) Injectable Solution | SY | 1 |
| 1716012 | vitamin A 100000 UNT/ML / vitamin D3 10000 UNT/ML / vitamin E 300 UNT/ML Injectable Solution | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| VITAMIN A Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59007-1041-1 | Vital E -A plus D3 | 250 mL in 1 BOTTLE, GLASS | INJECTION, EMULSION | 250 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59007-1041 | VITAL E - A PLUS D3 (VITAMIN E, VITAMIN A, VITAMIN D) INJECTION, EMULSION [STUART PRODUCTS, INC.] | 1 | 1 package rows | 20151024_f2d7b1dd-eca7-4e8c-82fc-cb3286cae502.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ALPHA-TOCOPHEROL, D- | ACTIVE INGREDIENT | N9PR3490H9 | 1 | |
| CHOLECALCIFEROL | ACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| VITAMIN A PALMITATE | ACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| .ALPHA.-TOCOPHEROL, D- | ACTIVE MOIETY | N9PR3490H9 | 1 | |
| CHOLECALCIFEROL | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| VITAMIN A | ACTIVE MOIETY | 81G40H8B0T | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59007-1041 | 59007-1041-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALPHA-TOCOPHEROL, D- | N9PR3490H9 | ACTIB |
| VITAMIN A PALMITATE | 1D1K0N0VVC | ACTIM |
| CHOLECALCIFEROL | 1C6V77QF41 | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| BENZYL ALCOHOL | LKG8494WBH | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SHAMPOO / TOPICAL | 1.25 %w/w | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / SOFT TISSUE | 40 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTICULAR | 1 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / SUBCUTANEOUS | 0.95 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRASYNOVIAL | 18 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 144 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SPRAY, METERED / NASAL | 5 mg/1ml | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SOFT TISSUE | 23 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / RECTAL | 124 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTERIAL | 0.9 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | LIQUID / INTRAVENOUS | 1.04 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SOLUTION / INTRA-ARTICULAR | 23 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRACAVITARY | 0.01 ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRA-ARTICULAR | 40 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SUBCUTANEOUS | 90 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / SUBCUTANEOUS | 225 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | LOTION / TOPICAL | 4000 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / ORAL | 360 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRALESIONAL | 23 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / TOPICAL | 185 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 18 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | CAPSULE / ORAL | 450 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SUBCONJUNCTIVAL | 252 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | GEL / VAGINAL | 100 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | TABLET, DELAYED RELEASE / ORAL | 2.31 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / INTRAMUSCULAR | 225 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SOLUTION / INTRAVENOUS | 242 mg | ||
| BENZYL ALCOHOL | BENZYL ALCOHOL | LKG8494WBH | SUPPOSITORY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg |
Adverse event summaries are temporarily unavailable. Other product information remains available.